Long COVID
From the Journals
Millions who had COVID-19 still don’t have sense of smell, taste
“If you lost your sense of smell, did you get it back? There’s about a one in four chance you didn’t. That’s terrible.”
Conference Coverage
Long COVID risk not higher with rheumatic diseases
“The data demonstrate that rheumatic disease itself is not a risk factor for long COVID. However, patients with rheumatic diseases are at a higher...
Feature
Menopause and long COVID: What women should know
Women at midlife who have long COVID seem to get specific, and severe, symptoms, including brain fog, fatigue, new-onset dizziness, and difficulty...
Latest News
New guidance on neurological complications of long COVID
The most common neurological symptoms are headache, weakness, muscular pain, nerve pain, tremors, peripheral nerve issues, sleep issues, and...
Conference Coverage
Could vitamin D supplementation help in long COVID?
“COVID-19 patients with low vitamin D levels are more likely to develop long COVID, but it is not yet known whether vitamin D supplements could...
Commentary
Clinical trials: Top priority for long COVID
Behavioral treatments including exercise, graded exercise therapy, and cognitive-behavioral therapy should not be trialed, let alone prioritized,...
Conference Coverage
Long-COVID rate may be higher with rheumatic diseases
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients...
Feature
Researchers seek to understand post-COVID autoimmune disease risk
Three large studies link past SARS-CoV-2 infection to new-onset autoimmune disease, but it is not yet clear what drives this relationship.
From the Journals
Long-COVID patients respond differently to COVID vaccines
Differences could explain why some people experience symptoms for months while others recover faster.
Feature
Long COVID mobile monitoring study hunts for answers
Researchers plan to use mobile monitoring devices in the federally-funded RECOVER Initiative to provide doctors and patients with a wealth of...
From the Journals
Trial shows some relief for long COVID fatigue, researchers say
It was one of the first randomized double-blind placebo controlled trial for a possible treatment for long COVID.